Efficacy of postoperative antiviral combined transcatheter arterial chemoembolization therapy in prevention of hepatitis B-related hepatocellular carcinoma recurrence

Chinese Medical Journal

Volumn 126, Issue 5, 2013, Pages 855-859

  Yan, Qiang ^a,b   Ni, Jun ^b   Zhang, Guo lei ^b   Yao, Xing ^b   Yuan, Wen bin ^b   Zhou, Lin ^a   Zheng, Shu Sen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Antiviral therapy; Disease free survival; Hepatocellular carcinoma; Recurrence; Transcatheter arterial chemoembolization

Indexed keywords

ADEFOVIR; ALPHA FETOPROTEIN; ANTIVIRUS AGENT; CISPLATIN; DNA; ENTECAVIR; FLUOROURACIL; HEPATITIS B (E) ANTIGEN; LAMIVUDINE; MITOMYCIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; ARTICLE; CHEMOEMBOLIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ECHOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE CARE; PROPHYLAXIS; RECURRENT DISEASE; RISK FACTOR;

ADULT; AGED; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED;

EID: 84875346003     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20121871     Document Type: Article

References (20)

1. Cheng SQ, Ding GH, Shi J, Guo WX, Zhao YX, Sheng L, et al. Role of antivirus therapy in treatment of hepatocellular carcinoma with chronic hepatitis B infection. Chin German J Clin Oncol 2005; 4: 330-333.
2. Arimura E, Kotoh K, Nakamuta M, Morizono S, Enjoji M, Nawata H. Local recurrence is an important prognostic factor of hepatocellular carcinoma. World J Gastroenterol 2005; 11: 5601-5606.
3. Ren ZG, Lin ZY, Xia JL, Ye SL, Ma ZC, Ye QH, et al. Postoperative adjuvant arterial chemoembolization improves survival of hepatocellular carcinoma patients with risk factors for residual tumor: A retrospective control study. World J Gastroenterol 2004; 10: 2791-2794.
4. Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatol Int 2008; 2: 263-283.
5. Zhou YM, Yang JM, Li B, Yin ZF, Xu F, Wang B, et al. Risk factors for early recurrence of small hepatocellular carcinoma after curative resection. Hepatobiliary Pancreat Dis Int 2010; 9: 33-37.
6. Zhou XD. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int 2002; 1: 35-41.
7. Cheung YS, Chan HLY, Wong J, Lee KF, Poon TCW, Wong N, et al. Elevated perioperative transaminase level predicts intrahepatic recurrence in hepatitis B-related hepatocellular carcinoma after curative hepatectomy. Asian J Surg 2008; 31: 41-49.
8. Sun HC, Tang ZY. Preventive treatments for recurrence after curative resection of hepatocellular carcinoma-A literature review of randomized control trials. World J Gastroenterol 2003; 9: 635-640.
9. Kim BK, Park JY, Kim do Y, Kim JK, Kim KS, Choi JS, et al. Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int 2008; 28: 393-401.
10. Lo CM, Liu CL, Chan SC, Lam CM, Poon RTP, Ng IOL, et al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 2007; 245: 831-842.
11. Chan HL, Tse CH, Mo F, Koh J, Wong VWS, Wong GLH, et al. High viral load and hepatitis B virus subgenotype Ce are associated with an increased risk of hepatocellular carcinoma. J Clin Oncol 2008; 26: 177-182.
12. Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 2006; 101: 1797-1803.
13. Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006; 295: 65-73.
14. Huang YH, Wang ZH, An SL, Zhou B, Zhou Y, Chan HL, et al. Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma. J Med Virol 2008; 80: 591-597.
15. Hung IF, Poon RT, Lai CL, Fung J, Fan ST, Yuen MF. Recurrence of hepatitis B-related hepatocellular carcinoma is associated with high viral load at the time of resection. Am J Gastroenterol 2008; 103: 1663-1673.
16. Sherman M. Predicting survival in hepatitis B. Gut 2005; 54: 1521-1523.
17. Shi XJ, Jin X, Wang MQ, Wei LX, Ye HY, Liang YR, et al. Effect of resection following downstaging of unresectable hepatocelluar carcinoma by transcatheter arterial chemoembolization. Chin Med J 2012; 125: 197-202.
18. Fan QS, Huo XK, Wang MQ, Liu FY, Duan F, Wang ZJ, et al. Efficacy and safety of transcatheter chemoembolization of the internal thoracic artery in patients with hepatocellular carcinoma. Chin Med J 2011; 124: 1374-1380.
19. Lai ECS, Lo CM, Fan ST, Liu CL, Wong J. Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg 1998; 133: 183-188.
20. Yamanaka J, Yamanaka N, Nakasho K, Tanaka T, Ando T, Yasui C, et al. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection. J Gastroenterol Hepatol 2000; 15: 1192-1198.